Synthesis and dopamine receptor affinities of 1-aminoethylhetero-tetralines
摘要:
A series of 1-aminoethylhetero-tetralines 3-6, which can be considered as opened-structure analogues of previously studied dopaminergic compounds 2, were synthesized. In the binding studies, to evaluate D-1 and D-2 activity, no significant affinity was observed towards both dopaminergic receptors.
Synthesis and dopamine receptor affinities of 1-aminoethylhetero-tetralines
摘要:
A series of 1-aminoethylhetero-tetralines 3-6, which can be considered as opened-structure analogues of previously studied dopaminergic compounds 2, were synthesized. In the binding studies, to evaluate D-1 and D-2 activity, no significant affinity was observed towards both dopaminergic receptors.
N(HETERO)-ARYL-N(HETERO)-TETRALIN-ALKYL-PIPERAZINE HAVING SEROTONINERGIC, DOPAMINERGIC AND ADRENERGIC ACTIVITY
申请人:FARMITALIA CARLO ERBA S.r.l.
公开号:EP0647222A1
公开(公告)日:1995-04-12
[EN] N(HETERO)-ARYL-N(HETERO)-TETRALIN-ALKYL-PIPERAZINE HAVING SEROTONINERGIC, DOPAMINERGIC AND ADRENERGIC ACTIVITY<br/>[FR] N(HETERO)-ARYL-N(HETERO)-TETRALIN-ALKYL-PIPERAZINE A ACTIVITE SEROTONINERGIQUE, DOPAMINERGIQUE ET ADRENERGIQUE
申请人:FARMITALIA CARLO ERBA S.R.L.
公开号:WO1994000441A1
公开(公告)日:1994-01-06
(EN) N(hetero)-aryl-N(hetero)-tetralinalkyl piperazine having serotoninergic, dopaminergic and adrenergic activity, the processes for their preparation and relative therapeutic compositions for the treatment of anxiety generated by depression, for the treatment of schizophrenia, cerebral ischemia, opium like and psycho stimulant substances abuse syndromes consciousness disorders such as senile dementia, vigilance and memory disorders. Parkinson's and Alzheimer's diseases and for the treatment of arterial hypertension.(FR) N(hétéro)-aryl-N(hétéro)-tétralin-alkyl-pipérazine à activité serotoninergique, dopaminergique et adrénergique, ses procédés de préparation, et compositions thérapeutiques associées destinées au traitement de l'angoisse provoquée par la dépression, au traitement de la schizophrénie, des accès ischémiques cérébraux, des syndromes dus à l'usage de substances psychostimulantes et opiacées, des troubles de la conscience tels que la démence sénile et les troubles de la vigilance et de la mémoire, et des maladies de Parkinson et d'Alzheimer, ainsi qu'au traitement de l'hypertension artérielle.
Synthesis and dopamine receptor affinities of 1-aminoethylhetero-tetralines
A series of 1-aminoethylhetero-tetralines 3-6, which can be considered as opened-structure analogues of previously studied dopaminergic compounds 2, were synthesized. In the binding studies, to evaluate D-1 and D-2 activity, no significant affinity was observed towards both dopaminergic receptors.